10.06.2011: Study Demonstrates Micromet's Blinatumomab Produces High Single-Agent Activity in Patients with Relapsed Acute Lymphoblastic Leukemia
• 75% of patients achieved a complete remission, with no evidence of remaining leukemic cells in blood or bone marrow
• Data add to a growing body of clinical evidence demonstrating blinatumomab's potential to be used across the course of the disease
more
...
12.04.2011: Pieris and Daiichi Sankyo Sign Therapeutic Collaboration to Develop Anticalin Therapeutics
Pieris AG announced today the signature of a
collaboration and license agreement with Daiichi Sankyo Company Limited, under which Pieris will apply its proprietary Anticalin scaffold technology to discover novel Anticalins against two Daiichi Sankyo targets.more
...
05.04.2011: Light-Harvesting Processes LHP2011
The third international conference "Light-Harvesting Processes LHP2011" will be held from April 10 – 14, 2011 in Staffelstein and is concerned with novel solar cells inspired by the natural process of photosynthesis. more
...
17.03.2011: AMSilk Closes 5 Million Euro Financing Round
AMSilk, a privately-held company specializing in the development and production of high performance materials based on spider silk, is announcing the successful completion of a 5 million Euro Series B financing round. more
...
18.02.2011: A Cancer Gene Keeps Itself in Check
Scientists of the Biozentrum, University of Würzburg describe feed-back loop of the oncogene Mycmore
...
09.02.2011: Evotec AG acquires Kinaxo Biotechnologies GmbH
Evotec AG today announced the signing of a definitive agreement to acquire all shares in Kinaxo Biotechnologies GmbH, a Munich-based drug discovery alliance company supporting the development of targeted drugs.more
...
19.10.2010: Monitoring lop-sided molecular encounters
New method can detect binding interactions in blood samplesmore
...
11.10.2010: KINAXO Enters Agreement with Bristol-Myers Squibb Company
Bristol-Myers Squibb Company has chosen KINAXO to support several of its drug discovery programs.more
...
06.10.2010: Prelude to third financing round
Hepa Wash GmbH was invited to showcase its patented liver support device at the MedTech Summit 2010 in Lausanne, Switzerland.more
...
28.09.2010: Pieris AG signs collaboration and license agreement with both Sanofi-Aventis and Sanofi Pasteur
Pieris AG announced today the signature of a collaboration and license agreement with both Sanofi-Aventis and Sanofi Pasteur, the vaccines division of the sanofi-aventis Group.more
...
03.09.2010: Opening of Roche’s Diagnostic Operations Complex in Penzberg
PENZBERG, Sep 02, 2010. The Swiss biotechnology and pharma company Roche has opened a new Diagnostic Operation Complex (DOC) at its Penzberg location. Roche has invested € 136 M...more
...
16.08.2010: BIO-Europe 2010 returns to Munich
Munich to become the capital of biotech dealmaking in November ...
more
...
10.08.2010: Eurofins MWG Operon Signs Contract to Supply Oligonucleotides to Research Councils of UK
Ebersberg, Germany, August 10, 2010 - Eurofins MWG Operon, international market leader and expert for custom oligonucleotide synthesis and RCUK Shared Services Centre Limited (RCUK SSC Ltd) have sign...more
...
05.08.2010: Proteros achieves growth rate of more than 30 % in 2009 and announces expansion of commercial organization in USA and Japan
Martinsried, Germany, August 5, 2010. Proteros confirmed its annual financial statement for 2009, which showed a growth rate, in revenues, in excess of 30% while maintaining profitability.
...more
...03.08.2010: Antisense Pharma (Regensburg) obtains IND of the FDA for clinical studies in the USA
REGENSBURG - 03. August 2010. The biopharmaceutical company Antisense Pharma announced today that the US-American Food and Drug Administration (FDA) has issued an Investigational New Drug (IND)-autho...more
...
26.07.2010: AbD Serotec Secures Exclusive Worldwide License to Key Diagnostic Antibody
Measurement of Parathyroid Hormone (PTH) a Valuable Diagnostic Tool during Parathyroid Surgery
more
...
21.07.2010: Süd-Chemie to build Germany´s largest plant for the biotechnological production of biofuels from straw
Süd-Chemie AG, one of the world´s leading specialty chemical companies for catalysts and adsorbents based in Munich is to build Germany´s largest plant to date for the production of climate-friendly,...more
...
19.07.2010: MediGene sells full European rights for Eligard® to Astellas for EUR 25 million and ongoing royalties
Martinsried/Munich, July 19, 2010. MediGene AG (Frankfurt, Prime Standard, MDG, TecDAX) announces the sale of full European marketing and distribution rights to Eligard® (leuprolide acetate, for the ...more
...
08.07.2010: Intana Announces Agreement with Johnson&Johnson to Provide Proprietary Spectroscopy Technology
Martinsried, Germany, July 7th, 2010. Intana Bioscience GmbH announced today that it has entered an agreement with Johnson & Johnson Pharmaceutical Research & Development, a division of Janssen Pharm...more
...
01.07.2010: MorphoSys Announces Clinical Milestone from Strategic Alliance
Second Clinical Milestone in 2010more
...
